Clinical Trial Imaging Market
Report ID: SQMIG35H2309
Report ID: SQMIG35H2309
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35H2309 |
Region:
Global |
Published Date: November, 2024
Pages:
194
|Tables:
101
|Figures:
66
Clinical Trial Imaging Market size was valued at USD 1.42 Billion in 2024 and is poised to grow from USD 1.53 Billion in 2025 to USD 2.8 Billion by 2033, growing at a CAGR of 7.82% during the forecast period (2026–2033).
Growing biotechnology and pharmaceutical industry are expected to drive market growth, coupled with increasing investments in research and development to develop the new drugs targeted to treat various diseases. Despite the ever-changing nature of the medical imaging industry, the biotechnology and pharmaceutical industries are experiencing steady growth. This is largely due to the increased investments in the medical imaging companies, as well as a phenomenon of mergers and acquisitions that incorporate advanced imaging technologies to facilitate the manufacture of medical devices clinical investigation.
Advances in technology have led to significant improvements in the collection, analysis, and presentation of clinical trial imaging data. Imaging technology, particularly image analysis software, offers a variety of advantages for clinical research, including consistency, accuracy, scalability, and compliance like the use of image analysis software to guide and manage the reader. Furthermore, increased use of the computer technology and increased computing power is expected to provide imaging in clinical trials. Quantitative Imaging Biomarker Alliance (QIBA) protocol standardized methods with uniform methods to be used to obtain estimates of realistic data in clinical trials and has led to imaging techniques.
Market snapshot - 2026-2033
Global Market Size
USD 1.32 Billion
Largest Segment
Project and Data Management Services
Fastest Growth
Operational Imaging Services
Growth Rate
7.82% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Clinical Trial Imaging Market is segmented by Service and Software, Modality, Therapeutic Area, End User, and Region. Based on Service and Software, the market is segmented into Services (Operational Imaging Services, Read Analysis Services, System And Technical Support Services, Trial Design And Consulting Services), Software. Based on Modality, the market is segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Others. Based on Therapeutic Area, the market is segmented into Oncology, Infectious Diseases, Neurology, Cardiovascular System Disorders, Endocrinology, Immunological Disorders, Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic And Government Research Institutes, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The project and data management services segment retained the market with the highest revenue share at 28.73% in 2023. Clinical trials using imaging typically require extensive data management and networking which is easy in several development stakeholders. Various segments including the real-time reporting, configuration and management of MRI sites, data management, and handles reporting and resolution of issues. Furthermore, the U.S. government has approved a cloud-based server to store all medical imaging records, including transcripts and reference images, to ensure protection against natural disasters. This system provides access to medical record quickly and easily.
The operational imaging services segment also led the market with the highest revenue share. These commercial imaging services include various imaging modalities such as MRI, CT, ultrasound, OCT, PET, and SPECT, for clinical trials in oncology, cardiovascular diseases, gastroenterology, musculoskeletal disorders, and medical device studies Imaging techniques are essential in clinical trials to provide needed evidence for an informed decision. The Food and Drug Administration Modernization Act (FDAMA) paved the manner for the use of imaging strategies in the medical tool and pharmaceutical manufacturing throughout clinical trials.
The computed tomography scanners segment led the market with the largest revenue share of 29.13% in 2023. Computed tomography (CT) systems had been widely used for medical diagnostic imaging due to their capability to provide detailed images of inner frame systems. X-ray laptop modeling is used for imaging, permitting physicians and researchers to look and measure adjustments in tissues and organs over time. CT systems are non-invasive and relatively smooth to use due to comparison retailers or radioactive CT snap shots, no injections are wished. This provides safety and accessibility for sufferers and researchers. In addition, researchers prefer CT scanners because CT systems can process huge quantities of information in a short time period, requiring researchers to collect and examine massive amounts of data from a couple of patients to identify developments and patterns. The ultrasound segment is predicted to develop rapidly at a CAGR of 8.01% from 2024 to 2030. Ultrasound system is broadly used within the worldwide marketplace due to its non-invasiveness and capability to provide real-time imaging of the organs and endocrinology. These devices are specially useful for cardiology, cancer, and obstetrics. Ultrasound gadgets are desired over different imaging modalities because of protection and shortage of dangerous radiation. In addition, ultrasound gadget is portable, cheaper, and easy to apply, making it best for clinical trial imaging. Examples of ultrasound devices utilized in scientific trial imaging include the GE Healthcare LOGIQ E10, Philips Epiq Elite, and Siemens Healthineers.
To get detailed segments analysis, Request a Free Sample Report
North America dominated the market with a revenue share of 40.73% in 2023. This dominance is primarily due to several factors, including leading outsourcing companies, impressive growth in the R&D activities in regional U.S. leads the number of clinical trials conducted. The market has captured a significant share of the North America region in the market due to factors such as demand for advanced medical imaging technologies in clinical research, numerous pharmaceutical and biotechnology companies in the region. Funding for clinical trials comes from a variety of institutions, including government, private investors, philanthropies, universities, and other research organizations but most of the money usually comes from the pharmaceutical company that has a strong financial interest in completing the trial.
The Asia Pacific region in the market is expected to grow at the fastest pace at a CAGR of 7.93% during the forecast period. This can be attributed to rapid population growth, increasing R&D activities in the region, and growing need for advanced treatment. According to Clinicaltrialsarena.Com, Asia-Pacific (APAC) witnessed growth as it accounted for an impressive 10% in scientific trials between 2017 and 2022, surpassing others in key regions which includes America, Europe, and the RoW. Most scientific investigations throughout all industries are attributed to Phase II medical trials, that have been fantastically solid over the last 5 years but the wide variety of Phase I trials inside APAC is also growing. Although the geographic distribution of Phase III trials is similar across regions, APAC remains is dominated by a larger urban population. The figures highlight the fastest CAGR during the forecast period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Pharmaceutical and Biotech R&D Activities
Increasing Prevalence of Chronic Diseases
High Cost of Imaging Technology
Legal Challenges and Compliance Issues
Request Free Customization of this report to help us to meet your business objectives.
Marketers are expanding their global footprint by establishing partnerships, collaborations and acquisitions to enter new market areas. Partnerships with research institutes and healthcare carriers which include Mayo Clinic and academic laboratories are often key and look at their technologies in an actual-global clinical setting. With a strategic partnership with the Mayo Clinic to foster innovation within the fields. This partnership ambitions to develop new technologies and solutions that could enable clinical analysis and improved affected person care.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the clinical trial imaging market witness's tremendous growth due to increasing R&D activities in pharmaceutical and biotechnology and increasing incidence of chronic diseases. However, the market faces challenges which include the growing imaging prices and regulatory requirements barriers proscribing their enormous adoption, in particular Key traits shaping the marketplace. Players consist of integration of AI for higher image analysis and shift to cloud-based totally imaging systems for shipping enhance collaboration and feasibility. As era keeps enhancing, clinical trial imaging will play a more and more vital function in enhancing the efficacy and safety of recent therapeutic interventions.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.42 Billion |
| Market size value in 2033 | USD 2.8 Billion |
| Growth Rate | 7.82% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Clinical Trial Imaging Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Trial Imaging Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Trial Imaging Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Clinical Trial Imaging Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
